• Clemex sells three PS3 instruments for Pharma applications

    22/08/2007 12:00:00 AM

    Wednesday, August 22, 2007 - Clemex Technologies Inc. (TSX Venture: CXG.a) announces today that it has recently sold three PS3 instruments for Particle Size and Shape analysis to clients in the pharmaceutical sector. The instruments were sold for a total of $306,475 to PPD of Middleton WI, USA, Intranasal Therapeutics inc R&D Laboratories of Lexington KY, USA and to Draxis Pharma of Montreal QC, Canada. Two of these clients will use their instrument primarily for the testing and development of nasal sprayed drugs and other fine powders while the third one will be using it primarily for the measurement of fine micronised particles. The three instruments are Research type, meaning that they include fully automated high performance microscopes. The President and CEO, Clément Forget declared the following: “We are quite pleased with these three orders received in a six week period. We have put a lot of efforts in the last year in the marketing of this new product and it now begins to payoff. We have several other prospects in line to purchase these systems and we will pursue our marketing and education efforts in order to close these sales in the next quarters.” He continued;, “Clemex has a substantial technological lead in automated Particle Size analysis by microscopy and an excellent reputation amongst instrument suppliers in the industry and we intend to capitalize on this as much as we can.

    About PPD

    PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 28 countries and more than 9,700 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients.

    About Intranasal Therapeutics Inc. Intranasal Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and disorders related to the central nervous system for which there is proven, unsatisfied consumer need. Their market-driven strategy is designed to capitalize on their unique expertise and proprietary technology to develop an array of promising new drug therapies, from product concept to commercialization.

    About Draxis Pharma. Draxis Pharma is a division of Draxis Specialty Pharmaceuticals Inc., a wholly owned subsidiary of Draxis Health Inc. is a manufacturer of outsourced pharmaceutical products in a broad range of dosage forms. Our strategy for success is based on outstanding quality, international regulatory compliance, superior technology transfer capabilities and consistent on-time performance. Products manufactured at Draxis Pharma are sold in over 100 countries and include the following dosage forms: sterile products, non-sterile products and radiopharmaceuticals. Sterile products include liquid and freeze-dried (lyophilized) injectables, sterile ointments and sterile creams.

    Specialty non-sterile products are produced as tablets, ointments, liquids and creams. Proprietary radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are provided through the DRAXIS Pharma division and radiopharmaceuticals are developed, produced and sold through the DRAXIMAGE division. DRAXIS Health employs approximately 500 staff in its Montreal facility.

    About Clemex Technologies, Inc.

    Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories. Clemex’s customer base spans the globe and encompasses prestigious Universities and Research Centers in many scientific domains, large and medium size manufacturing facilities in numerous industries including automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors.